105 related articles for article (PubMed ID: 7738490)
1. Cold exposure increases cyclic guanosine monophosphate in healthy women but not in women with Raynaud's phenomenon.
Leppert J; Ringqvist A; Ahlner J; Myrdal U; Sørensen S; Ringqvist I
J Intern Med; 1995 May; 237(5):493-8. PubMed ID: 7738490
[TBL] [Abstract][Full Text] [Related]
2. Seasonal variations in cyclic GMP response on whole-body cooling in women with primary Raynaud's phenomenon.
Leppert J; Ringqvist A; Ahlner J; Myrdal U; Walker-Engström ML; Wennmalm A; Ringqvist I
Clin Sci (Lond); 1997 Aug; 93(2):175-9. PubMed ID: 9301433
[TBL] [Abstract][Full Text] [Related]
3. Whole-body cooling increases plasma endothelin-1 levels in women with primary Raynaud's phenomenon.
Leppert J; Ringqvist A; Karlberg BE; Ringqvist I
Clin Physiol; 1998 Sep; 18(5):420-5. PubMed ID: 9784937
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon.
Ringqvist A; Jonason T; Leppert J; Ringqvist I
Clin Sci (Lond); 1998 Mar; 94(3):239-43. PubMed ID: 9616257
[TBL] [Abstract][Full Text] [Related]
5. Lower serum magnesium level after exposure to cold in women with primary Raynaud's phenomenon.
Leppert J; Aberg H; Levin K; Ringqvist I
J Intern Med; 1990 Sep; 228(3):235-9. PubMed ID: 2401874
[TBL] [Abstract][Full Text] [Related]
6. The effect of sympathetic blockade and cooling in Raynaud's phenomenon.
Engelhart M
Clin Physiol; 1990 Mar; 10(2):131-6. PubMed ID: 2318024
[TBL] [Abstract][Full Text] [Related]
7. A pathogenic role for endothelin in Raynaud's phenomenon?
Bottomley W; Goodfield M
Acta Derm Venereol; 1994 Nov; 74(6):433-4. PubMed ID: 7701873
[TBL] [Abstract][Full Text] [Related]
8. Role of digital artery adrenoceptors in Raynaud's disease.
Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
[TBL] [Abstract][Full Text] [Related]
9. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon.
Zamora MR; O'Brien RF; Rutherford RB; Weil JV
Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025
[TBL] [Abstract][Full Text] [Related]
10. Effects of cold pressor test on circulating atrial natriuretic peptide 99-126 (ANP) in patients with Raynaud's phenomenon and influence of treatment with magnesium sulphate and nifedipine.
Ringqvist I; Hedner T; Leppert J; Niklasson U; Edvinsson L
Clin Physiol; 1993 May; 13(3):271-80. PubMed ID: 8519163
[TBL] [Abstract][Full Text] [Related]
11. Limitation of finger systolic pressure measurement as a diagnostic test for primary Raynaud's phenomenon in a female population.
Leppert J
Clin Physiol; 1989 Oct; 9(5):457-65. PubMed ID: 2582732
[TBL] [Abstract][Full Text] [Related]
12. Toe systolic blood pressure after local cooling in primary Raynaud's phenomenon.
Kurozawa Y; Nasu Y
Int Angiol; 1994 Sep; 13(3):215-7. PubMed ID: 7822896
[TBL] [Abstract][Full Text] [Related]
13. Assessment of autonomic nervous function in patients with vibration syndrome using heart rate variation and plasma cyclic nucleotides.
Harada N; Kondo H; Kimura K
Br J Ind Med; 1990 Apr; 47(4):263-8. PubMed ID: 2159773
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of 5-hydroxytryptamine during sympathetic stimulation and in Raynaud's phenomenon.
Coffman JD; Cohen RA
Clin Sci (Lond); 1994 Mar; 86(3):269-73. PubMed ID: 8156737
[TBL] [Abstract][Full Text] [Related]
15. Effect of magnesium sulfate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon.
Leppert J; Myrdal U; Hedner T; Edvinsson L; Tracz Z; Ringqvist I
Angiology; 1994 Jul; 45(7):637-45. PubMed ID: 8024163
[TBL] [Abstract][Full Text] [Related]
16. The effect of cooling on toe systolic pressures in subjects with and without Raynaud's syndrome in the lower extremities.
Carter SA
Clin Physiol; 1991 May; 11(3):253-61. PubMed ID: 1893682
[TBL] [Abstract][Full Text] [Related]
17. Blood viscosity and local response to cold in primary Raynaud's phenomenon.
Jahnsen T; Nielsen SL; Skovborg F
Lancet; 1977 Nov; 2(8046):1001-2. PubMed ID: 72898
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic activation after two weeks of nifedipine treatment in primary Raynaud's patients and controls.
Leppert J; Nilsson H; Myrdal U; Edvinsson L; Hedner T; Ringqvist I
Cardiovasc Drugs Ther; 1993 Dec; 7(6):901-7. PubMed ID: 8011569
[TBL] [Abstract][Full Text] [Related]
19. Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects.
Ringqvist A; Leppert J; Myrdal U; Ahlner J; Ringqvist I; Wennmalm A
Clin Physiol; 1997 May; 17(3):269-77. PubMed ID: 9171967
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
